Literature DB >> 3804162

[Sleep deprivation (wakefulness therapy) as an antidepressant].

H Kuhs, R Tölle.   

Abstract

In this complete survey of publications concerning therapeutic sleep deprivation (including reports of a conference held in 1985) first the practical management and especially the advantages of sleep deprivation of the second half of the night are explained. After discussing the psychological conditions and methods of therapeutic evaluation the treatment results in endogenous depression (melancholia), the effectiveness of repetition and of combination with antidepressive pharmacotherapy, the comparison with electroconvulsive therapy and the predictors are described. Sleep deprivation is indicated in nearly every therapeutic situation, including drug-resistant melancholia, furthermore in severe neurotic depression and in depressive states of schizophrenic patients. Side effects are unimportant, and complications are almost absent. In addition psychophysiological, neuroendocrinological and biochemical investigations are reported, as far as they concern either the mechanism of action of sleep deprivation or chronobiological hypotheses of depression.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804162     DOI: 10.1055/s-2007-1001939

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  1 in total

1.  Single-case evaluation of sleep-deprivation effects by means of nonparametric time-series analysis (according to the HTAKA model)

Authors:  H J Möller; R Blank; E M Steinmeyer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.